Concepedia

Incidence of diabetes mellitus in patients treated with immune checkpoint inhibitors (ICI) therapy – A comprehensive cancer center experience

Zhen Zhang, Rajeev Sharma, Lamya Hamad, Grazyna Riebandt, Kristopher Attwood

Diabetes Research and Clinical Practice · 2023 · 17 citations · 7 references

DOI

Concepts

References

7

Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group

Igor Puzanov, Adi Diab, K. Abdallah et al. · Journal for ImmunoTherapy of Cancer · 2017 · 2K citations · Full text

, , +17

The Programmed Death-1 (PD-1) Pathway Regulates Autoimmune Diabetes in Nonobese Diabetic (NOD) Mice

Mohammed Javeed Ansari, Alan D. Salama, Tanuja Chitnis et al. · The Journal of Experimental Medicine · 2003 · 807 citations · Full text

, , +17

Immune checkpoint inhibitors: an emerging cause of insulin-dependent diabetes

Anupam Kotwal, Candace L. Haddox, Matthew S. Block et al. · BMJ Open Diabetes Research & Care · 2019 · 223 citations · Full text

, , +16

Genetic risk analysis of a patient with fulminant autoimmune type 1 diabetes mellitus secondary to combination ipilimumab and nivolumab immunotherapy

Jared R. Lowe, Daniel J. Perry, April K.S. Salama et al. · Journal for ImmunoTherapy of Cancer · 2016 · 108 citations · Full text

, , +17

Protective Role of Programmed Death 1 Ligand 1 (PD-L1)in Nonobese Diabetic Mice

Chia-Jen Wang, Feng‐Cheng Chou, Chi-Hong Chu et al. · Diabetes · 2008 · 86 citations · Full text

, , +16